Table 4 Effect of different treatments on plasma levels of liver enzymes, glucose, cholesterol, and triglycerides
From: Berberine-loaded albumin nanoparticles reverse aflatoxin B1-induced liver hyperplasia
Groups/parameters | Glucose (mg/dL) | Triglycerides (mg/dL) | Cholesterol (mg/dL) | ALT (U/L) | AST (U/L) | ALP (U/L) | LDH (U/L) | GGT (U/L) |
|---|---|---|---|---|---|---|---|---|
Sham control | 144.01* ± 2.54 | 86.37* ± 0.16 | 107.69* ± 0.12 | 45.64* ± 0.35 | 49.14* ± 0.25 | 52.3* ± 3.25 | 62.9* ± 6.35 | 23.2* ± 2.35 |
Tween control | 148.81* ± 0.26 | 81.97* ± 0.12 | 109.73* ± 0.14 | 43.24* ± 0.17 | 48.94* ± 0.11 | 58.2* ± 1.5 | 80.2#* ± 1.87 | 29.7* ± 0.95 |
Induction | 278.24# ± 0.23 | 450.73# ± 1.51 | 192.86# ± 0.25 | 96.45# ± 0.07 | 120.55# ± 0.35 | 275# ± 8.5 | 600.5# ± 12.4 | 80.1# ± 8.7 |
BER treatment | 180.8*# ± 0.93 | 250*# ± 3.8 | 168.64*# ± 10.3 | 70.31*# ± 0.18 | 82.11#* ± 0.32 | 160.3#* ± 8.8 | 258.3#* ± 9.7 | 60.5#* ± 6.4 |
BER-BSA NPs treatment | 160.9*#& ± 1.93 | 200*#& ± 6.9 | 150.97*#& ± 3.6 | 44.18*& ± 0.12 | 48.27*& ± 0.26 | 100.3#*& ± 7.6 | 189.1#*& ± 6.7 | 43.2#*& ± 1.54 |